Breaking News Instant updates and real-time market news.

2020-04-22 10:55:01 AGGZF AG Growth International $0.00 / + (+0.00%) 10:55 04/22/20 04/22 10:55 04/22/20 10:55	AG Growth International price target lowered to C$35 from C$55 at RBC Capital RBC Capital analyst Andrew Wong lowered the firm's price target on AG Growth International to C$35 from C$55 and keeps an Outperform rating on the shares. Interruptions and uncertainty from the COVID-19 pandemic have "put short-term pressure on earnings" and the analyst sees 2020 results being "negatively impacted."
AGGZF AG Growth International $0.00 / + (+0.00%) 04/20/20 Desjardins AG Growth International upgraded to Buy from Hold at Desjardins

2020-04-22 10:55:01

AGGZF

AG Growth International

$0.00 / + (+0.00%)

10:55

04/22/20

04/22

10:55

04/22/20

10:55

AG Growth International price target lowered to C$35 from C$55 at RBC Capital

RBC Capital analyst Andrew Wong lowered the firm's price target on AG Growth International to C$35 from C$55 and keeps an Outperform rating on the shares. Interruptions and uncertainty from the COVID-19 pandemic have "put short-term pressure on earnings" and the analyst sees 2020 results being "negatively impacted."

AGGZF AG Growth International

$0.00 / + (+0.00%)

04/20/20 Desjardins: AG Growth International upgraded to Buy from Hold at Desjardins

TODAY'S FREE FLY STORIES

Recommendations	Kopin price target raised to $12 from $5.50 at Ladenburg » 07:40 03/03/21 03/03 07:40 03/03/21 07:40 KOPN Kopin $9.92 / +0.78 (+8.53%) Ladenburg analyst Glenn… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options KOPN Kopin $9.92 / +0.78 (+8.53%) 02/23/21 Kopin director Collins sells almost $2M in company shares 02/23/21 Kopin trading resumes 02/23/21 Kopin trading halted, volatility trading pause 02/02/21 Kopin, HMDmd in development pact for wearable display system for surgeons KOPN Kopin $9.92 / +0.78 (+8.53%) 06:09 Today H.C. Wainwright Kopin downgraded to Neutral from Buy at H.C. Wainwright 01/11/21 H.C. Wainwright Kopin price target raised to $3.50 from $2 at H.C. Wainwright 08/25/20 Fly Intel: Top five analyst initiations 08/25/20 H.C. Wainwright Kopin initiated with a Buy at H.C. Wainwright KOPN Kopin $9.92 / +0.78 (+8.53%) 11/03/20 Kopin reports Q3 EPS (1c), consensus (2c) KOPN Kopin $9.92 / +0.78 (+8.53%) 03/02/21 Unusually active option classes on open March 2nd
Initiation	CuriosityStream initiated with a Buy at Needham » 07:39 03/03/21 03/03 07:39 03/03/21 07:39 CURI CuriosityStream $18.66 / -0.18 (-0.96%) Needham analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events Options CURI CuriosityStream $18.66 / -0.18 (-0.96%) 10/14/20 CuriosityStream to begin trading on Nasdaq with ticker 'CURI' after closing deal CURI CuriosityStream $18.66 / -0.18 (-0.96%) 06:28 Today Needham CuriosityStream initiated with a Buy at Needham 02/16/21 Fly Intel: Top five analyst initiations 02/16/21 Roth Capital CuriosityStream initiated with a Buy at Roth Capital 01/12/21 Benchmark CuriosityStream initiated with a Buy at Benchmark 04 Feb CURI CuriosityStream $18.66 / -0.18 (-0.96%) 02/01/21 Fly Intel: After-Hours Movers 01/06/21 Fly Intel: Pre-market Movers 03/23/21 CuriosityStream - CURI CURI CuriosityStream $18.66 / -0.18 (-0.96%) 01/21/21 Eighteen new option listings and one option delisting on January 21st
Initiation	Gemini Therapeutics initiated with a Buy at Jefferies » 07:39 03/03/21 03/03 07:39 03/03/21 07:39 GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) Jefferies analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 02/10/21 Gemini Therapeutics completes enrollment in Phase 2a Trial of GEM103 02/09/21 Gemini Therapeutics appoints Brian Piekos as CFO 02/08/21 Gemini Therapeutics completes business combination with FSDC, debuts on Nasdaq GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 03/02/21 Goldman Sachs Gemini Therapeutics initiated with a Buy at Goldman Sachs 02/16/21 Stifel Gemini Therapeutics initiated with a Buy at Stifel GMTX Gemini Therapeutics $16.05 / +0.46 (+2.95%) 02/09/21 Five new option listings and two option delistings on February 9th
Hot Stocks	Kaleido Biosciences announces anticipated near-term milestones » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) Anticipated Near-Term… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:38 Today Kaleido Biosciences sees cash runway into 1Q22 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:37 Today Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th
Hot Stocks	Dollar Tree sees FY21 store openings of 600 » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 DLTR Dollar Tree $99.03 / -0.16 (-0.16%) For FY21, the company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock 12/03/20 Dollar Tree Director Thomas Saunders sells almost $12M in company shares DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA 02/16/21 JPMorgan Dollar Tree price target raised to $134 from $130 at JPMorgan DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 07:36 Today Dollar Tree reports Q4 EPS $2.13, consensus $2.11 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 11/24/20 Fly Intel: Wall Street's top stories at midday 11/24/20 Fly Intel: Pre-market Movers 09:00 Today Dollar Tree - DLTR DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish

Hot Stocks	Kaleido Biosciences sees cash runway into 1Q22 » 07:38 03/03/21 03/03 07:38 03/03/21 07:38 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 11/02/20 Kaleido Biosciences announces anticipated milestones KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 07:37 Today Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th
Hot Stocks	Tradeweb Markets reports February total trading volume $20.4T » 07:37 03/03/21 03/03 07:37 03/03/21 07:37 TW Tradeweb Markets $73.33 / -0.44 (-0.60%) Tradeweb Markets reported… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 02/04/21 Tradeweb Markets reports $20T total volume traded in January 02/04/21 Tradeweb Markets sees FY21 CapEx $45M-$50M 02/02/21 Tradeweb Markets to acquire Nasdaq fixed income trade platform for $190M 02/02/21 Nasdaq to sell U.S. fixed income business to Tradeweb Markets TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 03/02/21 Morgan Stanley Tradeweb Markets resumed with an Overweight at Morgan Stanley 02/22/21 Goldman Sachs Tradeweb Markets upgraded to Buy from Neutral at Goldman Sachs 01/13/21 Compass Point Tradeweb Markets upgraded in relative call against MarketAxess at Compass Point 01/13/21 Compass Point Tradeweb Markets upgraded to Buy from Neutral at Compass Point TW Tradeweb Markets $73.33 / -0.44 (-0.60%) 02/04/21 Tradeweb Markets reports Q4 adjusted EPS 34c, consensus 34c 10/28/20 Tradeweb Markets reports Q3 EPS 30c, consensus 29c 23 Apr 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/29/21 Tradeweb Markets - TW
Earnings	Kaleido Biosciences reports Q4 EPS (56c), consensus (40c) » 07:37 03/03/21 03/03 07:37 03/03/21 07:37 KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events Options KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/14/21 Kaleido Biosciences announces interim results of controlled study of KB109 01/04/21 Kaleido Biosciences completes enrollment of 350 subjects in KB109 study 11/02/20 Kaleido Biosciences sees cash runway into 2H21 11/02/20 Kaleido Biosciences announces anticipated milestones KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 02/09/21 Piper Sandler Kaleido Biosciences initiated with an Overweight at Piper Sandler 01/14/21 Chardan Kaleido Biosciences price target raised to $17.50 from $10 at Chardan 12/23/20 JMP Securities Kaleido Biosciences initiated with an Outperform at JMP Securities 10/14/20 JPMorgan Kaleido Biosciences resumed with an Underweight at JPMorgan KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 11/02/20 Kaleido Biosciences reports Q3 EPS (65c), consensus (63c) 04 Feb 02 Jun 03/17/21 Kaleido Biosciences - KLDO 03/19/21 Kaleido Biosciences KLDO Kaleido Biosciences $9.56 / -0.12 (-1.24%) 01/28/21 new option listings on January 28th
Options	Unusual call flow in option market yesterday » 07:36 03/03/21 03/03 07:36 03/03/21 07:36 RKT Rocket Companies $41.70 / +17.4 (+71.60%) , NLS Nautilus $20.46 / +1.27 (+6.62%) Notable call activity was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Rocket Companies soars as short interest gets highlighted 03/02/21 Rocket resumes trading after volatility halt, shares up 57% to $38.07 03/02/21 Rocket Companies trading resumes 03/02/21 Rocket Companies trading halted, volatility trading pause NLS Nautilus $20.46 / +1.27 (+6.62%) 02/23/21 Nautilus falls -20.6% 02/22/21 Nautilus drops 8% to $24.50 after Q4 revenue misses consensus 02/22/21 Nautilus says demand for in-home fitness has not abated in 2021 12/30/20 Nautilus to change fiscal year to start in April and end in March RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 06:34 Today Zelman Rocket Companies downgraded to Hold from Buy at Zelman 03/02/21 RBC Capital Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital 03/02/21 Wells Fargo Wells says Rocket Companies Q4 results 'not good enough to support' today's move 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance NLS Nautilus $20.46 / +1.27 (+6.62%) 11/10/20 Lake Street Nautilus price target raised to $40 from $30 at Lake Street 11/10/20 Craig-Hallum Nautilus price target raised to $28 from $22 at Craig-Hallum 10/15/20 Lake Street Nautilus price target raised to $30 from $17 at Lake Street 10/14/20 Truist Nautilus price target raised to $28 from $18 at Truist RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 NLS Nautilus $20.46 / +1.27 (+6.62%) 02/22/21 Nautilus sees Q1 net sales growth of 55%-75% over last year 02/22/21 Nautilus reports Q4 EPS 89c, consensus 75c 11/09/20 Nautilus sees FY20 revenue $540M-$565M, consensus $448.61M 11/09/20 Nautilus reports Q3 adjusted EPS 87c, consensus 32c 06 Aug RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports NLS Nautilus $20.46 / +1.27 (+6.62%) 11/25/20 Peloton shipping delays may benefit Nautilus, WSJ reports 10/05/20 NordicTrack owner valued at over $7B in new funding round, Bloomberg says 09/09/20 Citron sets $30 target on Nautilus, predicts earnings 'blow out' RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers NLS Nautilus $20.46 / +1.27 (+6.62%) 02/23/21 Fly Intel: Wall Street's top stories for Tuesday 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: After-Hours Movers RKT NLS RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Callapalozza in Rocket Mortage echoes Gamestop squeeze 03/02/21 Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st NLS Nautilus $20.46 / +1.27 (+6.62%) 03/02/21 Aggressive buyer sweeps October calls in Nautilus 11/09/20 Nautilus options imply 29.0% move in share price post-earnings 09/21/20 Nautilus call volume above normal and directionally bullish 09/09/20 Unusually active option classes on open September 9th
Earnings	Dollar Tree reports Q4 EPS $2.13, consensus $2.11 » 07:36 03/03/21 03/03 07:36 03/03/21 07:36 DLTR Dollar Tree $99.03 / -0.16 (-0.16%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/16/21 SPAR Group appoints Mike Matacunas as president, CEO 02/04/21 Instacart announces new national delivery partnership with Family Dollar 12/07/20 Dollar Tree CEO sells 12.4K shares of common stock 12/03/20 Dollar Tree Director Thomas Saunders sells almost $12M in company shares DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Fly Intel: Pre-market Movers 02/25/21 BofA BofA double downgrades Dollar Tree to Underperform, sees multiple headwinds 02/25/21 BofA Dollar Tree downgraded to Underperform from Buy at BofA 02/16/21 JPMorgan Dollar Tree price target raised to $134 from $130 at JPMorgan DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 11/24/20 Dollar Tree reports Q3 EPS $1.39, consensus $1.15 11/23/20 Notable companies reporting before tomorrow's open 11/23/20 Notable companies reporting before tomorrow's open DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 11/24/20 Fly Intel: Wall Street's top stories at midday 11/24/20 Fly Intel: Pre-market Movers 09:00 Today Dollar Tree - DLTR DLTR Dollar Tree $99.03 / -0.16 (-0.16%) 12/16/20 Early notable gainers among liquid option names on December 16th 11/24/20 Early notable gainers among liquid option names on November 24th 10/23/20 Dollar Tree call volume above normal and directionally bullish

Recommendations	Arena Pharmaceuticals price target lowered to $100 from $106 at Cantor Fitzgerald » 07:35 03/03/21 03/03 07:35 03/03/21 07:35 ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) Cantor Fitzgerald analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 03/02/21 Arena Pharmaceuticals slides after IBS trial did not meet primary endpoint 03/02/21 Arena Pharmaceuticals reports topline results from Phase 2b CAPTIVATE trial 02/02/21 Arena Pharmaceuticals completes enrollment of ELEVATE UC 52 trial 12/08/20 Arena Pharmaceuticals achieves target enrollment for Phase 3 ELEVATE UC 52 trial ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 05:03 Today JonesTrading Arena Pharmaceuticals price target lowered to $94 from $101 at JonesTrading 01/28/21 JonesTrading Arena Pharmaceuticals initiated with a Buy at JonesTrading 11/19/20 SMBC Nikko Arena Pharmaceuticals initiated with an Outperform at SMBC Nikko 11/10/20 RBC Capital Arena Pharmaceuticals price target lowered to $76 from $80 at RBC Capital ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 02/23/21 Arena Pharmaceuticals reports Q4 EPS ($2.10), consensus ($1.85) 11/09/20 Arena Pharmaceuticals reports Q3 EPS ($1.69), consensus ($1.87) 28 May ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 11/05/20 Governor Cuomo says NY 'ripe' for pot legalization, amNewYork says 11/04/20 Marijuana legalization measures set to pass in five states, Tech Crunch says ARNA Arena Pharmaceuticals $76.67 / -3.44 (-4.29%) 03/02/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: Wall Street's top stories for Tuesday 11/10/20 Fly Intel: Wall Street's top stories at midday 11/10/20 Fly Intel: Pre-market Movers
Hot Stocks	Strongbridge Biopharma sees 2021 KEVEYIS revenue $34M-$36M » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Revenue consensus… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 07:33 Today Strongbridge Biopharma expects cash to fund operations into 1Q23 07:33 Today Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP
Hot Stocks	Ituran to distribute 48c per share cash dividend » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 ITRN Ituran $21.44 / -0.64 (-2.90%) Ituran announced that the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Events ITRN Ituran $21.44 / -0.64 (-2.90%) 07/21/20 Jefferies Ituran downgraded to Hold on South America exposure at Jefferies 07/21/20 Jefferies Ituran downgraded to Hold from Buy at Jefferies 09:00 Today Ituran - ITRN
Hot Stocks	Jones Lang LaSalle launches commercial partnership, investment in Roofstock » 07:34 03/03/21 03/03 07:34 03/03/21 07:34 JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) JLL announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/17/21 JLL appoints Gilda Perez-Alvarado as global CEO, Hotels & Hospitality 01/25/21 JLL appoints Ingrid Jacobs as head of diversity, inclusion 11/24/20 BP, Jones Lang LaSalle enter multi-year vested workplace evolution agreement 11/20/20 JLL names Rastogi chief product officer to lead JLL Technologies JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/26/21 JPMorgan Jones Lang LaSalle price target raised to $200 from $176 at JPMorgan 01/25/21 Goldman Sachs Jones Lang LaSalle initiated with a Buy at Goldman Sachs 12/21/20 JPMorgan Jones Lang LaSalle price target raised to $172 from $132 at JPMorgan 10/07/20 Keefe Bruyette Jones Lang LaSalle downgraded to Market Perform at Keefe Bruyette JLL Jones Lang LaSalle $178.34 / -0.7 (-0.39%) 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29 vs. $6.35 a year ago 02/09/21 Jones Lang LaSalle reports Q4 adjusted EPS $5.29, consensus $3.93 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 11/02/20 Jones Lang LaSalle reports Q3 adjusted EPS $2.99, consensus $1.25 10:00 Today Jones Lang LaSalle - JLL
Hot Stocks	Strongbridge Biopharma expects cash to fund operations into 1Q23 » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Assuming the availability… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 07:33 Today Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO 02/16/21 Strongbridge Biopharma appoints Richard Kollender as president, CFO SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP

Recommendations	HP Enterprise price target raised to $20 from $17 at BofA » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 HPE HP Enterprise $14.51 / -0.105 (-0.72%) BofA analyst Wamsi Mohan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options HPE HP Enterprise $14.51 / -0.105 (-0.72%) 01/27/21 HP Enterprise to build $35M+ supercomputer for NCAR 12/08/20 Verizon expands SD WAN portfolio with Silver Peak 12/01/20 HP Enterprise to relocate headquarters to Houston, Texas 11/17/20 Zuora announces Paul Heard as chief information officer HPE HP Enterprise $14.51 / -0.105 (-0.72%) 01/15/21 Fly Intel: Top five analyst upgrades 01/15/21 JPMorgan JPMorgan upgrades 'good contrarian long trade' HP Enterprise to Overweight 01/15/21 JPMorgan HP Enterprise upgraded to Overweight from Neutral at JPMorgan 12/16/20 Morgan Stanley HP Enterprise price target raised to $13.50 from $13 at Morgan Stanley HPE HP Enterprise $14.51 / -0.105 (-0.72%) 03/02/21 HP Enterprise raises FY21 adjusted EPS view to $1.70-$1.88, consensus $1.67 03/02/21 HP Enterprise sees Q2 adjusted EPS 38c-44c, consensus 38c 03/02/21 HP Enterprise reports Q1 adjusted EPS 52c, consensus 41c 12/01/20 HP Enterprise sees Q1 revenue down mid-single digits from Q4 HPE HP Enterprise $14.51 / -0.105 (-0.72%) 12/02/20 Fly Intel: Wall Street's top stories for Wednesday 12/02/20 Fly Intel: Wall Street's top stories at midday 12/01/20 Fly Intel: After-Hours Movers 10/16/20 Fly Intel: Wall Street's top stories for Friday 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/14/21 Hewlett Packard Enterprise Co. HPE HP Enterprise $14.51 / -0.105 (-0.72%) 12/01/20 Hewlett Packard Enterprise options imply 9.8% move in share price post-earnings 11/10/20 Hewlett Packard Enterprise put volume heavy and directionally bearish 10/14/20 Hewlett Packard Enterprise call volume above normal and directionally bullish 09/29/20 Hewlett Packard Enterprise put volume heavy and directionally bearish
Hot Stocks	Strongbridge Biopharma reports Q4 EPS (11c), consensus (12c) » 07:33 03/03/21 03/03 07:33 03/03/21 07:33 SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) Reports Q4 revenue $8.2M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 03/02/21 Strongbridge Biopharma submits NDA for RECORLEV 02/16/21 iBio appoints Robert Lutz as CFO and CBO 02/16/21 Strongbridge Biopharma appoints Richard Kollender as president, CFO 02/03/21 Strongbridge Biopharma announces employment inducement awards SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/08/20 JMP Securities Weakness in Strongbridge Biopharma 'a buying opportunity,' says JMP Securities 03/03/20 Fly Intel: Top five analyst initiations 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum 03/03/20 Craig-Hallum Strongbridge Biopharma initiated with a Buy at Craig-Hallum SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 01/06/21 Strongbridge Biopharma sees 2021 KEVEYIS revenue approx. $34M-$36M 01/06/21 Strongbridge Biopharma sees 2020 KEVEYIS revenue approx. $30.7M 01/06/21 Strongbridge Biopharma sees Q4 KEVEYIS revenue approx. $8.2M 10/29/20 Strongbridge Biopharma reports Q3 EPS (18c), consensus (13c) 17 Sep SBBP Strongbridge Biopharma $3.08 / -0.08 (-2.53%) 09/17/20 Fly Intel: Pre-market Movers 09/16/20 Fly Intel: After-Hours Movers 03/16/21 31st Annual Healthcare Virtual Conference 08:30 Today Strongbridge Biopharma - SBBP
Recommendations	Kohl's price target raised to $67 from $65 at Cowen » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 KSS Kohl's $57.36 / +0.41 (+0.72%) Cowen analyst Oliver Chen… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 KSS Kohl's $57.36 / +0.41 (+0.72%) 06:37 Today Citi Kohl's price target raised to $67 from $56 at Citi 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 03/01/21 Notable companies reporting before tomorrow's open 03/01/21 Notable companies reporting before tomorrow's open 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c KSS Kohl's $57.36 / +0.41 (+0.72%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday KSS Kohl's $57.36 / +0.41 (+0.72%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish
Recommendations	Dine Brands price target raised to $90 from $85 at Raymond James » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 DIN Dine Brands $78.83 / -2.795 (-3.42%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands says Applebee's SSS improving roughly 8% QTD from January 03/02/21 Dine Brands sees FY21 capital expenditures $14M 11/17/20 Dine Brands names John Peyton, president and CEO DIN Dine Brands $78.83 / -2.795 (-3.42%) 07:08 Today Barclays Dine Brands price target raised to $95 from $80 at Barclays 02/10/21 Deutsche Bank Dine Brands downgraded to Hold from Buy at Deutsche Bank 01/20/21 Wedbush Dine Brands added to Best List Ideas, target raised to $83 at Wedbush 01/06/21 Raymond James Dine Brands upgraded to Outperform from Market Perform at Raymond James DIN Dine Brands $78.83 / -2.795 (-3.42%) 03/02/21 Dine Brands reports Q4 adjusted EPS 39c, consensus 67c 10/28/20 Dine Brands reports Q3 EPS 80c, consensus 36c
Hot Stocks	Dish, DraftKings announce strategic agreement » 07:32 03/03/21 03/03 07:32 03/03/21 07:32 DISH Dish $33.11 / +0.26 (+0.79%) , DKNG DraftKings $68.56 / -0.14 (-0.20%) DISH Network (DISH) and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/23/21 ADT Inc., Dish partner to bring smart home security to more customers 02/22/21 Dish signs master lease agreement with SBA Communications 02/16/21 Dish announces seven new tower agreements 02/08/21 Dish selects Aviat Networks for 5G microwave wireless transport DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/26/21 DraftKings MUPs for B2C segment up 44% vs. 4Q19 02/25/21 Bill introduced in Florida Senate to authorize sports wagering 02/25/21 Nevada reports January statewide gaming win down 26.6% to $761.85M 02/25/21 DraftKings names Cal Ripken Jr. as special advisor to board of directors DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Oppenheimer Verizon, AT&T downgraded to Perform on valuation at Oppenheimer 02/23/21 Fly Intel: Top five analyst downgrades 02/23/21 Pivotal Research Dish downgraded to Hold from Buy at Pivotal Research 12/04/20 Guggenheim Dish downgraded to Neutral from Buy at Guggenheim DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/01/21 Craig-Hallum DraftKings price target raised to $70 from $65 at Craig-Hallum 03/01/21 Canaccord DraftKings price target raised to $80 from $65 at Canaccord 03/01/21 Northland DraftKings price target raised to $70 from $55 at Northland 03/01/21 Benchmark DraftKings price target raised to $69 from $66 at Benchmark DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/22/21 Dish reports Q4 EPS $1.24, consensus 75c 11/06/20 Dish reports Q3 EPS 86c, consensus 70c DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open 02/25/21 Notable companies reporting before tomorrow's open 07 Oct 19 Jun DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 11/18/20 Dish 'improperly' received $3.3B in spectrum discounts, FBN says 11/02/20 Dish offers services to DoD's proposed 5G network project, WSJ reports 10/15/20 Dish, DirecTV merger again squashed by DOJ, NY Post reports 10/06/20 AT&T's auction of DirecTV turning into a 'fire sale," NY Post says DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/02/21 Hedgeye adds DraftKings as a Best Idea Short 03/02/21 Connecticut, Mohegan Tribe reach deal on sports betting, The Day reports 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 02/23/21 Starbucks upgrade, Kroger downgrade among today's top calls on Wall Street 02/22/21 Fly Intel: Pre-market Movers DKNG DraftKings $68.56 / -0.14 (-0.20%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/26/21 Bet On It: Florida and Texas trying to get in on the action 02/26/21 Fly Intel: Wall Street's top stories at midday 03/09/21 DraftKings Inc DISH DKNG DISH Dish $33.11 / +0.26 (+0.79%) 02/25/21 Early notable gainers among liquid option names on February 25th 02/04/21 Dish Network put volume heavy and directionally bearish 12/22/20 Unusual call flow in option market yesterday 12/21/20 Dish Network put volume heavy and directionally bearish DKNG DraftKings $68.56 / -0.14 (-0.20%) 02/02/21 DraftKings call volume above normal and directionally bullish 01/27/21 DraftKings call volume above normal and directionally bullish 01/26/21 DraftKings call volume above normal and directionally bullish 01/12/21 DraftKings call volume above normal and directionally bullish

Downgrade	BankUnited downgraded to Neutral from Buy at Janney Montgomery Scott » 07:31 03/03/21 03/03 07:31 03/03/21 07:31 BKU BankUnited $42.03 / -0.025 (-0.06%) Janney Montgomery Scott… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings BKU BankUnited $42.03 / -0.025 (-0.06%) 02/19/21 DA Davidson BankUnited downgraded to Neutral from Buy at DA Davidson 02/19/21 DA Davidson BankUnited downgraded to Neutral from Buy at DA Davidson 01/25/21 RBC Capital BankUnited price target raised to $42 from $39 at RBC Capital 01/08/21 UBS BankUnited downgraded to Neutral from Buy at UBS BKU BankUnited $42.03 / -0.025 (-0.06%) 01/21/21 BankUnited reports Q4 EPS 89c, consensus 70c 10/28/20 BankUnited reports Q3 EPS 70c, consensus 63c
Upgrade	Itron upgraded to Buy from Hold at Argus » 07:29 03/03/21 03/03 07:29 03/03/21 07:29 ITRI Itron $117.75 / -0.06 (-0.05%) Argus analyst John Eade… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ITRI Itron $117.75 / -0.06 (-0.05%) 02/17/21 Bsquare, Itron extend pact over industrial IoT innovation 01/19/21 Itron and Versant Power collaborate to modernize electricity grid in Maine 10/05/20 ON Semiconductor appoints Itron CEO Thomas Deitrich to board 10/05/20 Itron, Con Ed confirm, NYS affirmed its consent approval for Itron ERT module ITRI Itron $117.75 / -0.06 (-0.05%) 07:19 Today Argus Itron upgraded to Buy from Hold at Argus 02/25/21 Oppenheimer Itron price target raised to $127 from $75 at Oppenheimer 01/08/21 Raymond James Itron downgraded to Outperform from Strong Buy at Raymond James 01/08/21 Raymond James Itron downgraded to Outperform from Strong Buy at Raymond James ITRI Itron $117.75 / -0.06 (-0.05%) 02/24/21 Itron sees FY21 EPS $2.15-$2.55, consensus $2.26 02/24/21 Itron reports Q4 EPS 65c, consensus 30c 11/02/20 Itron reports Q3 EPS 61c, consensus 25c 03/08/21 Itron
Recommendations	Otis Worldwide price target raised to $77 from $75 at Cowen » 07:29 03/03/21 03/03 07:29 03/03/21 07:29 OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) Cowen analyst Cai Von… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/10/21 Otis Worldwide selected to supply elevators, escalators in three Canadian cities 01/11/21 Otis Worldwide recommends shareholders reject TRC Capital 'mini-tender' offer 01/11/21 CVS Health names Laurie Havanec as Chief People Officer OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 10/07/20 JPMorgan Otis Worldwide price target raised to $79 from $75 at JPMorgan 09/24/20 Wolfe Research Otis Worldwide upgraded to Outperform from Peer Perform at Wolfe Research 09/24/20 JPMorgan Otis Worldwide pullback due to 'unwarranted concerns,' says JPMorgan 07/29/20 Credit Suisse Otis Worldwide price target raised to $66 from $55 at Credit Suisse OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/01/21 Otis Worldwide sees FY21 adjusted EPS $2.67-$2.77, consensus $2.62 02/01/21 Otis Worldwide reports Q4 non-GAAP EPS 66c, consensus 59c 10/26/20 Otis Worldwide raises FY20 adj. EPS view to $2.42 from $2.20-$2.30 10/26/20 Otis Worldwide reports Q3 adj. EPS 69c, consensus 56c OTIS Otis Worldwide $65.46 / +0.55 (+0.85%) 02/01/21 Fly Intel: Pre-market Movers 10/26/20 Fly Intel: Pre-market Movers 03/04/21 Otis Worldwide - OTIS
Hot Stocks	Anghami to list on Nasdaq New York via Vistas Media Acquisition Company merger » 07:28 03/03/21 03/03 07:28 03/03/21 07:28 VMAC Vistas Media Acquisition Company $10.25 / +0.05 (+0.49%) Anghami, a music… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	Iridium upgraded to Outperform from Market Perform at Raymond James » 07:28 03/03/21 03/03 07:28 03/03/21 07:28 IRDM Iridium $39.45 / -2.47 (-5.89%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings IRDM Iridium $39.45 / -2.47 (-5.89%) 02/19/21 Iridium CEO sells 62.1K shares of common stock 02/12/21 Collegium Pharmaceutical to replace Iridium in S&P 600 at open on 2/12 02/12/21 Iridium to replace Monolithic Power in S&P 400 at open on 2/12 02/10/21 Iridium board approves $300M share repurchase program IRDM Iridium $39.45 / -2.47 (-5.89%) 04:40 Today Raymond James Iridium upgraded to Outperform from Market Perform at Raymond James 02/12/21 Fly Intel: Top five analyst downgrades 02/12/21 Barclays Barclays double downgrades Iridium with stock ahead of fundamentals 02/12/21 Barclays Iridium downgraded to Underweight from Overweight at Barclays IRDM Iridium $39.45 / -2.47 (-5.89%) 02/11/21 Iridium sees FY21 service revenue growth of 3% 02/11/21 Iridium reports Q4 EPS (6c), consensus (8c) 10/20/20 Iridium reports Q3 EPS (3c), consensus (11c)

Events

Earnings calls, analyst events, roadshows and more

OPTN
Today at 08:00

Optinose - OPTN Conference Calls
BQ
Today at 08:00

Boqii - BQ Conference Calls
ISEE
Today at 08:00

Iveric bio - ISEE Conference Calls
TSHA
Today at 08:00

Taysha Gene Therapies - TSHA Conference Calls
Today at 08:15

ADP Employment Report: Private Payrolls M/M: February 2021 Government Event
TAST
Today at 08:30

Carrols Restaurant - TAST Conference Calls
PASG
Today at 08:30

Passage Bio - PASG Conference Calls
CECE
Today at 08:30

CECO Environmental - CECE Conference Calls
SBBP
Today at 08:30

Strongbridge Biopharma - SBBP Conference Calls
WEN
Today at 08:30

Wendy's - WEN Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer $9.14 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares DGII X DGII Digi International Secondary Managers: Piper Sandler $23.46 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham $35.91 4M Shares
Fri	No deals

View All Syndicate Announcements »

AG Growth International price target lowered to C$35 from C$55 at RBC Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access